DongKook Pharmaceutical Revenue

DongKook Pharmaceutical had revenue of 223.74B KRW in the quarter ending March 31, 2025, with 13.67% growth. This brings the company's revenue in the last twelve months to 839.08B, up 12.32% year-over-year. In the year 2024, DongKook Pharmaceutical had annual revenue of 812.17B with 11.10% growth.

Revenue (ttm)

839.08B

Revenue Growth

+12.32%

P/S Ratio

0.91

Revenue / Employee

741.89M

Employees

1,131

Market Cap

765.76B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	812.17B	81.17B	11.10%
Dec 31, 2023	730.99B	69.35B	10.48%
Dec 31, 2022	661.65B	67.45B	11.35%
Dec 31, 2021	594.19B	35.09B	6.28%
Dec 31, 2020	559.10B	76.82B	15.93%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,898.69B
Celltrion	3,662.23B
ALTEOGEN	151.65B
Yuhan	2,114.76B
SK Biopharmaceuticals	578.00B
HLB Co., Ltd.	74.64B
PharmaResearch	392.31B
LigaChem Biosciences	146.42B

Revenue Rankings